14-day Premium Trial Subscription Try For FreeTry Free

Here's Why You Should Retain CVS Health (CVS) Stock For Now

01:51pm, Monday, 04'th Apr 2022 Zacks Investment Research
Investors are optimistic about CVS Health (CVS) owing to continued progress in its consumer-centric digital solutions.

Bio-Rad (BIO) Thrives on Global Sales and Testing Uptake

01:15pm, Friday, 01'st Apr 2022 Zacks Investment Research
Bio-Rad's (BIO) underlying Life Science business' core revenues grow on strong uptake of Droplet Digital PCR as well as the qPCR business.
Bio-Rad's (BIO) underlying Life Science business' core revenues grow on strong uptake of Droplet Digital PCR as well as the qPCR business.

Here's Why You Should Hold on to Exact Sciences (EXAS) Stock

12:54pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Investors are optimistic about Exact Sciences (EXAS) on strong buoyed by Cologuard volume growth.

Omnicell (OMCL) Progresses With Intelligent Infrastructure Tools

03:22pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Omnicell's (OMCL) IVX Station robotic compounding technology apparently supports three times the throughput speed of the current IV robotic technology.

Edwards Lifesciences (EW) Up 7.5% Since Q4 Earnings Release

12:43pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Edwards Lifesciences' (EW) stock rallies on impressive fourth-quarter performance and bullish 2022 guidance.
Bio-Rad Laboratories provides a range of products for the life science and clinical diagnostics markets.

Here's Why You Should Hold on to Align Technology (ALGN) Now

12:59pm, Tuesday, 29'th Mar 2022 Zacks Investment Research
Investors are optimistic about Align Technology (ALGN) on the growing market adoption of the iTero Element 5D Plus imaging system.

Alcon (ALC) Publishes Dividend, New Board Member Addition Plans

04:21pm, Monday, 28'th Mar 2022 Zacks Investment Research
Alcon's 2022 AGM is set to take place in a closed format without the personal presence of shareholders.

Neogen's (NEOG) Q3 Earnings Miss Estimates, Margins Down

04:54pm, Friday, 25'th Mar 2022 Zacks Investment Research
Robust segmental performance and contributions from the Soleris product line drive the top line for Neogen (NEOG) in third-quarter of fiscal 2022 results.

Here's Why You Should Hold on to Thermo Fisher (TMO) Stock Now

04:08pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Investors are optimistic about Thermo Fisher (TMO) on its progress with COVID-19-related products and services.

QIAGEN (QGEN) QuantiFeron Hits New Sales Landmark in TB Testing

02:10pm, Thursday, 24'th Mar 2022 Zacks Investment Research
According to QIAGEN (QGEN), QuantiFERON is different from other IGRA tests based on its efficient workflow.

Henry Schein (HSIC) Stock Moves Up 16.9%: What's Driving It?

12:55pm, Wednesday, 23'rd Mar 2022 Zacks Investment Research
Henry Schein (HSIC) stock rallies on strong fourth-quarter performance and bullish 2022 EPS guidance.

Syneos Health (SYNH) Clinical Solutions Arm Grows Amid Cost Woe

12:47pm, Wednesday, 23'rd Mar 2022 Zacks Investment Research
Despite the near-term COVID-19 challenges, Syneos Health (SYNH) remains confident about the long-term strength of its business given the robust backlog and the unique market position.

Thermo Fisher's (TMO) New Buyouts Aid, Cost Pressure Ails

04:23pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
Thermo Fisher's (TMO) high degree of response to the pandemic has enabled it to accelerate its growth strategy, strengthen customer relationships, and bump up investments.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE